Caleb has over 20 years of operating, startup, and financing experience in life science and healthcare companies. He plays an instrumental role in sourcing and structuring deals and works closely with portfolio companies to form strategic partnerships and to develop commercialization and marketing strategies. He is an experienced venture capital investor and board member, having served on over a dozen boards including representing Excel on the Boards of Aileron Therapeutics, Aventura (acquired by Philips), Ayogo Health, ClearData, Cleveland Heartlab, InfoBionic, Molecular Templates, Oculus Health, ShapeUp (acquired by Virgin Pulse), Saladax Biomedical, and MedVentive (acquired by McKesson).
Prior to joining Excel, Caleb was a Principal at Biotechonomy, where he financed and managed several entrepreneurial ventures, including Synthetic Genomics, where he was also the Director of Finance, BioTrove (acquired by Life Technologies), Biocius (acquired by Agilent Technologies), and Xcellerex (acquired by GE), where he was recruited to organize a turnaround and was a member of the Board of Directors.
Prior to becoming a venture capitalist, Caleb was an award-winning sales and marketing executive at medical device and diagnostics companies. He received his M.B.A. from Babson College, magna cum laude, where he was a Babson Fellow in the Center for Technology Enterprise. He received a B.A. in Biology and a minor in Economics from Colby College.